Inhaled GM-CSF Reduces the Need for Whole Lung Lavage (WLL) and Improves Gas Exchange in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) PatientsEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
35 years of the Italian cohort of Pulmonary Alveolar Proteinosis (PAP)EUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Hyaluronan in the pathogenesis of lung fibrosis associated to autoimmune Pulmonary Alveolar Proteinosis (aPAP)EUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Children's ILDs survivors in adulthood: a European StudyEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosisEUROPEAN RESPIRATORY REVIEWIF10.42024-08-140OAAI
Disseminated nocardiosis and anti-GM-CSF antibodiesEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASESIF32024-02-201PRE
Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patientsEUROPEAN RESPIRATORY JOURNALIF212023-11-1612OAAI
COVID-19 in patients with Pulmonary Alveolar Proteinosis A European multicenter studyEUROPEAN RESPIRATORY JOURNALIF212022-12-013PRE
An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP)SCIENTIFIC REPORTSIF3.92022-05-242OAAI
Lung fibrosis in Pulmonary Alveolar Proteinosis (PAP): different stages of a syndrome or distinct diseases?EUROPEAN RESPIRATORY JOURNALIF212021-11-254PRE
Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPFORPHANET JOURNAL OF RARE DISEASESIF3.52021-02-2730OAAI
Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)EUROPEAN RESPIRATORY JOURNALIF212020-10-280PRE
Clinical, functional and radiologic progression in Interstitial pneumonia with autoimmune features (IPAF): a prospective cohort-studyEUROPEAN RESPIRATORY JOURNALIF212020-10-280PRE
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar ProteinosisNEW ENGLAND JOURNAL OF MEDICINEIF78.52020-10-2261OAAI
Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasisEUROPEAN RESPIRATORY JOURNALIF212019-12-1213OAAI
Potential clinical utility of MUC5B and TOLLIP single nucleotide polymorphisms (SNP) in in the management of patients with IPFEUROPEAN RESPIRATORY JOURNALIF212019-11-212PRE
The natural history of Pulmonary Alveolar Proteinosis (PAP): data from the Italian National Reference CenterEUROPEAN RESPIRATORY JOURNALIF212019-11-211PRE